Rich Gliklich

Rich Gliklich is a highly accomplished individual with an extensive educational background and a wealth of experience in the medical and healthcare industry.

He holds a Bachelor of Arts (BA) in Molecular Biophysics from Yale University and pursued further studies by obtaining an MD from Harvard Medical School, where he also completed a residency program in Otolaryngology.

Rich Gliklich's academic journey also includes being a Charles Dana Scholar in Outcomes Research at the University of Pennsylvania.

Throughout his career, Rich has been involved in various prestigious organizations, showcasing his leadership and expertise.

He has previously served as the CEO of OM1, Inc. (formerly Better Outcomes) and held the position of XIR & Partner at General Catalyst Partners.

Additionally, Rich Gliklich has contributed to academia as the Leffenfeld Professor at Harvard Medical School and has been a member of the Board of Directors at Cyft.

His significant roles also include being the President of Quintiles Outcome at Quintiles and the Founder/CEO/Chairman of Outcome.

Rich Gliklich's vast professional experience and educational achievements position him as a valuable asset in the field of medical research and healthcare outcomes.